Blockade of the CXCL10–CXCR3 axis has been shown to inhibit the infiltration of inflammatory cells, including T cells and macrophages, into inflamed joints and to decrease the severity of arthritis and bone and cartilage destruction in animal models of RA [6, 17]. Here, CXCR3 is linked to arthritic joint disease.